Immunogenicity and safety of MVA-BN vaccine administered 5 years after a two-dose primary series in DR Congo: a prospective cohort study

The Lancet Infectious Diseases 2026

View at publisher
Authors: Lalita Priyamvada, Faisal S. Minhaj, Toutou Likafi, Elisabeth Pukuta, Elisabeth Muyamuna, William C Carson, Margaret Moriarty, Sergio Rodriguez, Taina Joseph, Joelle Kabamba, Gaston Kokola, Robert Shongo Lushima
+10 more Jean-Jacques Muyembe-Tamfum, Christine M Hughes, Brett W Petersen, Yon Yu, Agam Rao, Andrea M. McCollum, Didine Kaba, Béatrice Nguete, Panayampalli S. Satheshkumar, Michael B Townsend
DOI: 10.1016/s1473-3099(26)00001-0
Cited by: 5
References: 24

Fields of Study & Subjects

Vaccine Coverage and Hesitancy Immune responses and vaccinations Bacterial Infections and Vaccines

Publication details

Journal / source
The Lancet Infectious Diseases
Publisher
Elsevier BV
Volume
26
Issue
6
Pages
571–580
Publication date
10 March 2026
Language
EN